Speaker

Laura Coates is an Associate Professor and NIHR Clinician Scientist whose research focuses on optimal therapeutic strategies in psoriatic arthritis (PsA).  Her PhD focused on the development of the minimal disease activity criteria for PsA and establishment of the TICOPA trial, the first study to show the benefit of treating to target in PsA. Her research is clinical and focuses on psoriatic arthritis and the spondyloarthritides including early diagnosis of PsA, development of PsA specific and validated outcome measures, optimal treatment pathways and strategies in PsA.  She is chair of the British PsA Consortium (BritPACT) and a member of GRAPPA.